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Abstract: The tumor necrosis factor-alpha (TNF-α) cytokine receptor system modulates 
apoptosis in many cell types, so we have investigated the role of sTNFR1 in bacterial 
lipopolysaccharide  (LPS)-induced  cell  death  in  cultured  human  decidual  stromal  cells, 
hypothesizing  that  sTNFR1  might  play  a  central  role  in  this  action.  In  this  work  we 
characterized  in  vitro  decidual  stromal  cell  viability  with  LPS  treatment  and  LPS  and 
sTNFR1 co-treatment. We found that LPS treatment induced decidual stromal cell death in 
a dose-dependent manner and that sTNFR1 blocked the effect of the LPS treatment. There 
was  a  significant  proliferation  among  cells  co-incubated  with  LPS  at  10  µg/mL  and 
sTNFR1 at 0.1 µg/mL compared with LPS and sTNFR1 at 0.01, 0.05, 0.2 and 0.5 µg/mL (p 
< 0.01). This study demonstrated that LPS led to decidual stromal cell death in vitro but 
sTNFR1  down-regulates  the  cell  death  due  to  LPS  under  the  same  conditions.  Taken 
together, these results suggested that sTNFR1 could participate in a protective mechanism 
against endotoxin. 
Keywords:  Decidual  stromal  cell  (DSC);  soluble  tumor  necrosis  factor  receptor  1 
(sTNFR1);  membrane  tumor  necrosis  factor  receptor  1  (mTNFR1);  pregnancy; 
lipopolysaccharide (LPS). 
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1.  Introduction 
 
The immune system is tightly regulated during pregnancy in order to avoid rejection of the semi-
allogenic fetus, and this seems to contribute to the development of a normal pregnancy. Cytokines are 
believed to be important in maintaining pregnancy and in the initiation of labor in humans. Tumor 
necrosis  factor-alpha  (TNF-α)  is  a  multifunctional  Th1  cytokine  with  roles  in  regulating  hormone 
synthesis, placental architecture, and embryonic development [1]. Increased placental TNF-α levels 
have  been  associated  with  pregnancy  failure  in  mice  [2],  and  elevated  serum  TNF-α  levels  are 
associated with the first-trimester threatened abortion-complicated pregnancies with adverse outcome 
in humans [3]. The administration of TNF-α increases abortion rates [4], and blockage of TNF-α has 
been identified as a potential therapy for the pregnancy complications of antiphospholipid syndrome in 
murine abortion models [5]. It is believed that TNF-α promotes apoptotic cell death in fetal membrane 
tissues [6] and prolonged or excessive production of TNF-α represents an important etiologic factor in 
inflammatory-based tissue injury [7]. 
During  early  pregnancy  in  mice,  the  implantation  sites  are  highly  sensitive  to  proinflammatory 
molecules such as lipopolysaccharide (LPS) [8]. LPS is a toxic component of the cell walls of Gram-
negative bacteria, and has been associated with adverse developmental outcome, including embryonic 
resorption and intra-uterine fetal death in rodents [9]. Numerous studies show that LPS administration 
resulted  in  increase  of  TNF-α  in  maternal  serum,  amniotic  fluid  and  placenta  [10-12].  Indeed,  in 
response to LPS, TNF-α is produced in large amounts earlier than any other cytokine. TNF-α has been 
associated with LPS-induced fetal loss and growth restriction in remaining viable fetuses [13].  
TNF has two different receptors, a 55-kDa (TNFR1) and a 75-kDa one (TNFR2). Both types of 
TNFRs  are  shed  from  the  cell  surface  and  exist  as  soluble  receptors.  TNF  and  soluble  TNFRs 
(sTNFRs) compose the system that relates with both Th1 and Th2 types of immune response because 
sTNFRs neutralize TNF. It has been found that TNF-activity can be inhibited in vivo and in vitro by 
administration of sTNFR (sTNFr-IgG), as demonstrated by successful inhibition of tissue damage in 
experimental autoimmune uveoretinitis [14]. Injection of sTNFRs neutralized TNF and abortion rate 
was reduced in mice [15]. These observations led us to hypothesize that the ability of LPS to induce 
embryonic resorption can be suppressed by sTNFR1 in humans. To test this hypothesis, the role of 
sTNFR1  in  LPS-induced  cell  viability  in  cultured  human  DSCs  was  investigated.  This  anti-TNF 
treatment increased the decidual stromal cell (DSC) viability in vitro.  
 
2. Results and Discussion 
 
2.1. Suppression of viability /survival of DSCs by LPS in a dose-dependent manner 
 
LPS in concentrations from 10 ng/mL to 1 mg/mL significantly suppressed viability of DSCs. Thus, 
the mean ± SEM spectrophotographic optical density for the cultured DSCs when exposed to various 
concentrations of LPS was 0.42 ± 0.03, 0.39 ± 0.01, 0.30 ± 0.02, 0.37 ± 0.01, 0.36 ± 0.02 at 10 ng/mL, 
100 ng/mL, 10 µg/mL, 100 µg/mL, and 1 mg/mL of LPS, respectively. Figure 1 shows data on the rate 
of  suppression  of  DSCs  cultured  in  the  presence  of  various  concentrations  of  LPS  for  24  h.  The Int. J. Mol. Sci. 2009, 10                       
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concentration of LPS that provided a most decreased viability of DSCs was 10 µg/mL. Thus, this 
concentration was selected for use in the final series of experiments. 
 
Figure 1. A dose-dependent effect of LPS on suppression of DSC viability by MTT test. 
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The DSCs were cultured for 24 h in the presence of various concentrations of LPS. The value 
represents cell suppression rate of five independent experiments. 
 
2.2. Viability /Survival of DSCs by sTNFR1 in a dose-dependent manner 
 
Co-incubated of DSCs with LPS and sTNFR1 for 24 h resulted in cell outgrowth. The mean ± SEM 
optical  density  for  the  cultured  DSCs  when  treated  with  a  combination  of  LPS  at  10  µg/mL  and 
sTNFR1 was 0.43 ± 0.01, 0.43 ± 0.01, 0.49 ± 0.02, 0.41 ± 0.15, 0.38 ± 0.15 at 0.01 µg/mL, 0.05 
µg/mL, 0.1 µg/mL, 0.2 µg/mL, 0.5 µg/mL of sTNFR1, respectively.  
 
Figure 2. A dose-dependent effect of sTNFR1 on survival of DSCs by MTT test. 
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The DSCs were cultured for 24 h in the presence of 10 ug/mL of LPS with various concentrations 
of  sTNFR1  (0.01  µg/mL,  0.05  µg/mL,  0.1  µg/mL,  0.2  µg/mL,  0.5  µg/mL  each).  The  value 
represents cell proliferation rate of five independent experiments. Int. J. Mol. Sci. 2009, 10                       
 
 
2013
sTNFR1  thus  suppressed  the  decrease  in  DSC  viability  induced by LPS. The concentration of 
sTNFR1  that  provided  a  statistically  significant  viability  rate  of  DSCs  was  0.1  µg/mL  (p  < 0.01) 
(Figure 2).  
 
2.3. TNFR1 expression on cultured DSCs 
 
To examine whether cell death is caused by LPS through regulation of TNFR1 expression, we 
performed RT-PCR and immunohistochemistry analysis to measure the expression of TNFR1 both at 
the  protein  and  mRNA  level.  For  the  expression  of  TNFR1  at  the  mRNA  level,  RT-PCR  was 
performed, using specific primers for TNFR1; primers for GAPDH were used as internal controls. 
Unstimulated DSCs expressed low levels of mTNFR1 mRNA (TNFR1 / GAPDH = 0.52 ± 0.045), and 
this was no further increase or decrease with exposure to various concentrations of LPS (Figure 3). For 
the expression of TNFR1 at the protein level, DSCs were stained with polyclonal antibody to TNFR1. 
A brown-yellow reaction product was observed in the cellular membrane and cytoplasm of DSCs. But, 
compared to unstimulated DSCs, no significant difference of mTNFR1 positive staining intensity was 
observed  in  DSCs  following  treatment  with  various  concentrations  of  LPS.  The  sTNFR1  did  not 
increase or decrease TNFR1 mRNA and mTNFR1 protein expression. These data suggested that the 
protective effect of sTNFR1 isn’t related to up-regulation or down-regulation of mTNFR1. 
Figure 3. mRNA expression of TNFRI in cultural decidual stromal cells in response to 
lipopolysaccharide  (LPS).  An  inverted  image  of  a  representative  RT-PCR  reaction  is 
shown in the left six panels (747 bp). A, unstimulated cells; B, 1 mg/mL of LPS; C, 100 
µg/mL of LPS; D, 10 µg/mL of LPS; E, 100 ng/mL of LPS; F, 10 ng/mL of LPS. The right 
panel (G) is GAPDH (500 bp). 
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2.4. Discussion 
 
Investigation of decidual cells in vitro provides a powerful approach to the study of the maternal 
environment and its role in the establishment and maintenance of pregnancy. DSCs are one of the 
principle cell types found in the placenta. To study how bacteria may affect DSCs, we cultured DSCs 
treated for 24 h with LPS and examined DSC proliferation suppression. Results with the MTT assay 
showed stimulation more than suppression in DSC proliferation, demonstrating that LPS has a potent 
in vitro effect on inhibiting cell proliferation in this important DSC type .  
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As the TNF-α cytokine receptor system has been shown to modulate apoptosis in many cell types 
[16-18], we cultured DSCs from normal first-trimester pregnant females and determined mTNFR1 
response to a bacterial product. The results described in this study show that TNFR1 expression at the 
mRNA and protein level is present in unstimulated DSCs, in accordance with observations reported by 
Arntzen and Menon [19,20]. But the up-regulation of mTNFR1 does not take place for cells to respond 
to LPS stimulation in this study. It is not clear that there is biologic plausibility to a bacterial product 
response of mTNFR1 in human decidua. 
In this series of experiments, we find that sTNFR1 modulates the proliferation of cultured human 
DSCs in response to the potent bacterial product LPS. The sTNFR1 increases the DSC proliferation 
from  the  first-trimester  pregnancy  undergoing  LPS  stimulation,  and  suggests  that  sTNFR1  could 
participate in a protective mechanism against endotoxin. We also find that 0.1 µg/mL concentration of 
sTNFR1 provided the greatest proliferation rate of DSCs. There is no increased viability of DSCs with 
an increasing concentration of sTNFR1, which may explain the inconsistent in vivo serum sTNFR1 
level results of women with early spontaneous miscarriages [21,22].  
It  has  been  found  that  explants  from  both  amnion  and  choriodecidua  produce  TNF  upon  LPS 
stimulation,  and  LPS  increased  production  of  TNF  from  decidual  cells  with  a  subsequent  release 
prostaglandins [19,23]. Reduction of the biological activities of TNF can be accomplished by several 
different,  but  highly  specific  strategies,  which  involve  soluble  receptors,  receptor  antagonists  and 
inhibitors  of  proteases  that  convert  inactive  precursors  to  active,  mature  molecules.  The  sTNFR1 
represents the extracellular domains of the TNFR1. After shedding by proteinase TNF-α converting 
enzyme, the sTNFR1 circulates in many body fluids and retains its ability to bind circulating TNF-α. 
Depending  on  their  relative  concentrations,  sTNFRs  have  been  suggested  to  either  block  TNF-α 
binding to mTNFRs and thus the subsequent biological responses [24] or to enhance TNF-α action by 
stabilization of the homotrimeric cytokine [25]. Elevated sTNFR1 level has been found in serum in 
association with inflammatory and infectious diseases, suggesting a direct or indirect implication of the 
TNF system in the pathophysiology of these diseases [26,27]. Since decidua is most to be involved at 
an early point in the host immune response to ascending microbial invasion of the upper genital tract, 
understanding and modulating decidual immune response is of critical importance. For this reason, our 
finding of a promotion of DSC death in response to bacterial products and a reduction of DSC death 
after incubation with sTNFR1 suggests that sTNFR1 may be a useful immunomodulatory agent in the 
therapies  for  infection-related,  early  spontaneous  miscarriage.  Future  investigations  exploring  the 
immunomodulatory role of sTNFR1 in an animal model of infection-induced spontaneous miscarriage 
are warranted. 
 
3. Materials and Methods 
 
3.1. Cell cultures 
 
Decidual specimens from elective terminations between 7 and 10 weeks of gestation were obtained 
under Department of Science and Research approval at the First Hospital of Xi’an Jiaotong University 
Medical School, P.R China. Tissues were rinsed with 0.9% saline to remove blood cells and mucus. 
Then, the tissues were minced and digested with 0.25% trypsin, as well as 20 mg/L DNase in RPMI Int. J. Mol. Sci. 2009, 10                       
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1640 medium containing 100 U/mL penicillin and 100 µg/mL streptomycin (Hyclone Co, America) in 
a 37 °C shaking water bath for 2 h. After washing with sterile phosphate-buffered saline (PBS), the 
digestate was washed three times and subjected to consecutive filtration through 100 µm and 200 µm 
Millipore filters, respectively. The filtrate was centrifuged at 2,000 g for 3 min. The pellet of mixed 
cells was washed twice and resuspended in RPMI 1,640 containing 100 U/mL penicillin, 100 µg/mL 
streptomycin  and  10%  fetal  calf  serum  and  seeded  on  polystyrene  tissue  culture  dishes,  grown  to 
confluence in a standard 95% air: 5% CO2 incubator at 37 °C. After five passages, by standard methods 
of trypsin treatment, the cells were > 95% pure as determined by immunohistochemical staining with 
antibodies to vimentin. These cells were used for the experiments.  
 
3.2. Incubation experiments 
 
Using human DSC cultures, we placed 0.125 × 10
6 cells in each well of a 12-well plate and let them 
adhere overnight. The cells were treated for 24 h with LPS at 1 mg/mL, 100 µg/mL, 10 µg/mL, 100 
ng/mL, and 10 ng/mL and dose–response experiments were performed. A series of 24 h incubations 
were performed under both LPS at 10 µg/mL and sTNFR1 at 0.01 µg/mL, 0.05 µg/mL, 0.1 µg/mL, 0.2 
µg/mL, 0.5 µg/mL each. Cellular viability was confirmed with each dose condition using a MTT [3-
(4,5-dimethylthiazole-2-yl)-2,5-diphenyl tetrazolioum bromide] assay according to the manufacturer’s 
instructions. 
 
3.3. TNFR1 mRNA of DSCs by reverse transcription-PCR (RT-PCR) 
 
The extraction of total cellular RNA was based on the single-step method. Cells were lysed by the 
addition of 1.0 mL of TRI-reagent solution (Invitrogen, USA) for every 1 × 10
6 cells and solubilized by 
passing  the  lysate  through  a  l  mL  pipette.  RNA  was  extracted  and  precipitated  according  to  the 
manufacturer’s instructions. The final pellet was resuspended in 50  L DEPC. First strand DNA was 
synthesized  at  42  °C  for  60  min  using  1   g  of  total  RNA,  1   L  of  AMV  reverse  transcriptase 
(Fermentas, USA), 1  L of oligo(dT) primer, dNTP (0.5 mM each of dGTP, dATP, dTTP, and dCTP) 
and 4  L of MgCl2 in RT buffer. The DNA was then amplified using 1  L of Taq DNA polymerase 
(Tiangen,  German),  1   L  of  sequence-specific  primers  against  human  TNFR1  (sense,  5’-
ATCTCTATGCCCGAGTCTCAACC-3’;  antisense,  5’-  CTCAATCTGGGGTAGGCACAAC-3’  for 
727 bp products), in PCR buffer (20 mM Tris-HCl, pH 8.4, 50 mM KC1 and 2 mM MgCl2) for 28 
cycles by PCR Thermal Cycle (FORMA Co. USA). The amplification profile involved denaturation at 
94 °C for 30 sec, primer annealing at 57 °C for 30 sec, and extension at 72 °C for 30 sec. Primers for 
GAPDH (sense, 5’-AGCCAAAAGGGTCATCATCT-3’; antisense, 5’-CCACCTGGTGCTCAGTGT 
AG-3’ for 500 bp) were added in the same tube, and the amount of GAPDH cDNA generated was used 
as an internal control. A 20  L sample of a 50  L PCR mixture was electrophoresed on a 1% agarose 
gel, stained in ethidium bromide, and photographed by the image analysis system. Levels of TNFR1 
mRNA  were  calculated  in  arbitrary  units  as  the  proportion  of  TNFR1  PCR  product  intensity  to 
GADPH PCR product intensity from the same RNA sample. 
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3.4. Membrane TNFR1 (mTNFR1) protein of DSCs by Immunohistochemistry 
 
DSCs growing on 2-well chamber slides were fixed for 10 min in 4% paraformaldehyde (PFA)/0.1 
PBS  (pH  7.2  –  7.6),  washed  twice  with  PBS  and  permeabilized  for  8  min  with  0.1%  Triton  X-
100/PBS. The fixed cells were incubated with a rabbit polyclonal anti-human TNFR1 antibody diluted 
at 1 : 25 (Wuhan Boster Biotechnology Co., China) and a mouse monoclonal anti-human vimentin 
antibody  diluted  at  1:500  (DAKO,  Denmark)  for  2  hours  at  37  °C,  followed  by  incubation  with 
biotinylated goat anti-rabbit IgG and goat anti mouse IgG for 30 min. For the negative control, the 
primary antibody was omitted. The cells were then incubated in DAB reagent and counterstained with 
hematoxylin  and  coverslipped  using  Protexx  mounting  media  (DAB-Stock  Stain  box;  Zymed 
Laboratories,  USA).  A  positive  reaction  for  mTNFR1  protein  was  defined  as  a  brown-yellow 
granulation in the cellular membrane and cytoplasm. Negative cells had clear cell structure without 
brown granulation in their cellular membrane and cytoplasm. 
 
3.5. Statistical analysis 
 
The results of cellular viable assay and mTNFR1 expression from three experiments were presented 
as mean ± SEM. A two-sample assuming equal variances Student t-test was applied to test the 
statistical significance where p < 0.05. 
 
4. Conclusions 
 
In this study we have demonstrated that LPS led to decidual stromal cell death in vitro, but  sTNFR1 
increased the DSC proliferation from the first trimester of pregnancy following LPS stimulation. Taken 
together, these results suggested that sTNFR1 could participate in a protective mechanism against LPS 
endotoxin. 
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